HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical Outcome of Laparoscopic Partial Nephrectomy].

Abstract
The purpose of this study was to evaluate the safety and feasibility of laparoscopic partial nephrectomy with a small renal tumor. Between September 2004 and October 2014, 69 patients who underwent laparoscopic partial nephrectomy in Kansai Rosai Hospial were examined. The mean patient age was 60.3 years, and the mean tumor size was 24.5 mm. The mean estimated blood loss was 111 cc. The mean cold ischemic time was 59.7 minutes, and the mean warm ischemic time was 31.3 minutes. There were 5 complications : intraoperative ureteral injury, blood transfusion, postoperative perinephric hematoma, portsite bleeding, urinary fistula, respectively. All of the cases were cured with non-surgical treatment except ureteral injury which was repaired intraoperatively. The postoperative eGFR loss was 11%. At present, no patients have developed local recurrence or distant metastasis. The initial outcome of laparoscopic partial nephrectomy in our hospital was satisfactory in terms of safety, renal function and cancer control.
AuthorsMasayuki Okamoto, Isao Taguchi, Masato Okuno, Takaki Ishida, Yasuyoshi Okamura, Gaku Kawabata
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 61 Issue 8 Pg. 317-20 (Aug 2015) ISSN: 0018-1994 [Print] Japan
PMID26411653 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Renal Cell (surgery)
  • Female
  • Humans
  • Kidney Neoplasms (pathology, surgery)
  • Laparoscopy (instrumentation, methods)
  • Male
  • Middle Aged
  • Nephrectomy
  • Postoperative Complications
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: